JELLY BEANS GROUP Co., Ltd.
Notice of Conclusion of Exclusive Distribution Agency Agreement for the “iHEAL” Brand in Japan
Entered into an exclusive domestic distribution agreement for the Korean femcare brand “iHEAL.” Jelly Beans will serve as the Japanese master distributor, aiming for full-scale sales in the second half of 2027 through direct sales, wholesale, and online channels. Also presenting brand strength, market opportunity, and sales strategy.
Key Figures
- Contract start timing: Planned to commence full-scale sales in the second half of fiscal year ending January 2027
- Brand items: 6 items
- Market size (Japan): 80.4 billion yen (2024 estimate)
AI要約
Section Header
This disclosure centers on the signing of an exclusive distribution agreement for the Japanese market of the Korea-origin femcare brand iHEAL, outlining the contractual structure (three-party agreement), each party’s roles (BIOLAB to manufacture, AIDEN LAB JAPAN to import and distribute, Jelly Beans to handle domestic exclusive distribution and marketing), and the rollout strategy (multichannel including direct sales, wholesale, and online) as well as the anticipated start date for sales. It describes market opportunities in the Japanese femcare market growth and the brand’s strengths, emphasizing synergies for the Japanese market.
Section 2 Header
Looking ahead, sales are planned to commence in the second half of fiscal year ending January 2027, with a focus on growing the market through direct sales, wholesale, and online channels. In the mid-to-long term, the company plans to expand domestic sales through multichannel deployment, leveraging the longstanding female customer base of women’s footwear and related synergies.
Jelly Beans Group Co., Ltd.
Company overview · Stock price · Financial data · All IR
